1. FRI0378 GENERAL SAFETY AND TOLERABILITY OF SUBCUTANEOUS TANEZUMAB FOR THE TREATMENT OF OSTEOARTHRITIS: A POOLED ANALYSIS OF RANDOMIZED, PLACEBO-CONTROLLED TRIALS. (2nd June 2020) Authors: Berenbaum, F.; Schnitzer, T.; Kivitz, A.; Viktrup, L.; Hickman, A.; Pixton, G.; Brown, M.; Davignon, I.; West, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Joint safety and neurologic events with subcutaneous tanezumab or oral nonsteroidal anti-inflammatory drugs in subgroups of patients with osteoarthritis from an 80-week phase 3 study. (April 2021) Authors: Hunter, D.J.; Radominski, S.; Rodriguez Ulloa, S.; Goranov, I.; Radunovic, G.; Chang, C.; Pixton, G.; Hickman, A.; Fountaine, R.J.; Brown, M.T.; Viktrup, L.; West, C. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Observed efficacy of subcutaneous tanezumab or oral nonsteroidal anti-inflammatory drugs in patients with osteoarthritis: subgroup analyses of a phase 3 study. (April 2021) Authors: Hunter, D.J; Radominski, S.; Ulloa, S. Rodriguez; Goranov, I.; Radunovic, G.; Chang, C.; Pixton, G.; Hickman, A.; Fountaine, R.J.; Brown, M.T.; Viktrup, L.; West, C. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip. (April 2019) Authors: Bessette, L.; Schnitzer, T.; Khan, A.; Pixton, G.; Viktrup, L.; Davignon, I.; Tive, L.; Brown, M.; West, C. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Total joint replacements in three phase 3 studies of tanezumab in patients with osteoarthritis. (April 2021) Authors: Carrino, J.A.; McAlindon, T.E.; Vignon, E.; Brown, M.T.; Fountaine, R.J.; Pixton, G.; Viktrup, L.L.; West, C.; Verburg, K.M. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗